{"id":5109,"date":"2014-11-14T11:25:52","date_gmt":"2014-11-14T10:25:52","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=5109"},"modified":"2014-11-14T12:13:55","modified_gmt":"2014-11-14T11:13:55","slug":"indagine-civica-sullesperienza-dei-pazienti-alluso-dei-farmaci","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/indagine-civica-sullesperienza-dei-pazienti-alluso-dei-farmaci\/","title":{"rendered":"Civic survey on patients' experience with respect to the use of medicines"},"content":{"rendered":"

Nearly half would not change therapy to take generics.\u00a0<\/i><\/b>More than half of the patients interviewed take 2 to 3 drugs a day<\/strong>\u00a0(24.8 and 28.9%), the 10.5% even more than four. Approximately one in five patients experience this\u00a0forget to take the therapy<\/strong>, to one in seven of getting the wrong dosage of the drug. Poor compliance and little information<\/em><\/p>\n

Thursday, November 13, 2014 \u2013 CITTADINANZATIVA.it<\/a><\/p>\n

\"\"The survey was conducted between August and October 2014 and involved 619 patients suffering from chronic pathologies belonging to Associations adhering to the CnAMC. Among the patients interviewed, the following pathologies prevailed: Crohn's disease and ulcerative colitis (47.5%), renal disease (18.5%), hypertension (15.2%), autoimmune and rheumatological diseases (13.2%) , psoriasis (10,6%), oncological diseases (10,5%). Laws\u00a0The communicated<\/b><\/a>\u00a0and download\u00a0the report<\/a><\/b><\/p>","protected":false},"excerpt":{"rendered":"

Quasi met\u00e0 non cambierebbe terapia per assumere generici.\u00a0Oltre la met\u00e0 dei pazienti intervistati assume dai 2 ai 3 farmaci al giorno\u00a0(24,8 e 28,9%), il 10,5% anche pi\u00f9 di quattro. All\u2019incirca ad un paziente su cinque accade di\u00a0dimenticare di assumere la terapia, ad uno su sette di sbagliare il dosaggio del farmaco. Scarsa compliance e poca …<\/p>","protected":false},"author":4,"featured_media":5112,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[26],"class_list":["post-5109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=5109"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5109\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5112"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=5109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=5109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=5109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}